ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

MOHAMMAD IBRAHIM MD

At A Glance: This Prescriber in 2012

Infectious Disease

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

16,047Medicare Part D Prescriptions Filled, Including Refills

Rank: 3 out of 86

$1.73M Total Retail Price of All Prescriptions

Rank: 8 out of 86

364 Patients Receiving at Least One Drug in Part D
55%Patients 65 Years and Older
89% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New Jersey
Lower avg

Schedule Two
Controlled Substances

17% of this provider’s 364 patients filled at least one prescription for a schedule two drug, compared to an average of 8%.

Schedule Three
Controlled Substances

10% of this provider’s 364 patients filled at least one prescription for a schedule three drug, compared to an average of 1%.

Risky Drugs to Seniors

4% of this provider’s 7,312 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.

Brand Name Drugs

46% of this provider’s prescriptions were for brand-name drugs, compared to an average of 49%.

Prescription Price

$108 was the average price of a prescription from this provider, compared to $288 among peers.

Prescriptions per Patient

44 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New Jersey
GLIMEPIRIDE 543 255 1 39
JANUVIA 534 261 2 37
SYNTHROID 474 264 3 56
SIMVASTATIN 421 239 4 5
ACTOS 417 215 5 49
OMEPRAZOLE 359 145 6 8
CRESTOR 312 115 7 9
ATORVASTATIN CALCIUM 300 149 8 12
AMLODIPINE BESYLATE 297 165 9 3
METFORMIN HCL 276 130 10 17
FUROSEMIDE 274 136 11 21
JANUMET 274 159 11 63
ENDOCET 254 61 S2 13 18
GABAPENTIN 240 80 14 25
NEXIUM 224 125 15 14
ZOLPIDEM TARTRATE 223 80 16 11
DIOVAN HCT 192 82 17 20
PIOGLITAZONE HCL 189 104 R 18 97
MELOXICAM 186 103 19 27
CLOPIDOGREL 186 111 19 34
LOVAZA 186 84 19 35
METOPROLOL SUCCINATE 182 84 22 15
ACTOPLUS MET 174 74 23 101
PROAIR HFA 168 42 24 19
GLYBURIDE-METFORMIN HCL 152 61 R 25 59
ATENOLOL 148 88 26 80
CLOTRIMAZOLE-BETAMETHASONE 141 49 27 42
DIOVAN 140 74 28 40
METFORMIN HCL ER 131 53 29 96
PLAVIX 128 67 30 47
CARVEDILOL 127 84 31 52
NOVOLOG MIX 70-30 FLEXPEN 127 77 31 100
ALENDRONATE SODIUM 127 85 31 29
GLIPIZIDE XL 121 53 34 116
OXYCODONE HCL 120 14 S2 35 33
LOSARTAN-HYDROCHLOROTHIAZIDE 119 72 36 41
TRAMADOL HCL 118 67 37 62
INSULIN SYRINGE 117 38 38 120
CELEBREX 116 66 39 61
HYDROCODONE-ACETAMINOPHEN 113 32 S3 40 103
NOVOFINE 32 111 50 41 122
ADVAIR DISKUS 107 56 42 32
ONGLYZA 104 41 43 127
LYRICA 95 42 44 69
METOPROLOL TARTRATE 94 62 45 26
NAPROXEN 92 39 46 82
IBUPROFEN 87 40 47 65
CLONIDINE HCL 86 28 48 55
TRAMADOL HCL-ACETAMINOPHEN 83 63 49 92
CYMBALTA 82 0 50 87
ZETIA 82 60 50 78
LIPITOR 82 57 50 91
FENOFIBRATE 81 37 53 105
NATEGLINIDE 78 56 54 141
LISINOPRIL 78 29 54 31
GLIPIZIDE ER 77 45 56 142
PANTOPRAZOLE SODIUM 76 0 57 109
LOSARTAN POTASSIUM 74 52 58 60
CYCLOBENZAPRINE HCL 73 19 R 59 85
LIDODERM 73 41 59 75
PIOGLITAZONE-METFORMIN 72 33 R 61 150
LEVOTHYROXINE SODIUM 71 25 62 16
SERTRALINE HCL 71 44 62 95
LEVOXYL 68 44 64 154
ENALAPRIL MALEATE 67 28 65 24
TAMSULOSIN HCL 67 26 65 45
HUMALOG MIX 75-25 66 12 67 155
ESCITALOPRAM OXALATE 64 19 68 84
PRAVASTATIN SODIUM 63 51 69 49
ISOSORBIDE MONONITRATE ER 62 60 70 118
AZITHROMYCIN 62 21 70 28
AMLODIPINE BESYLATE-BENAZEPRIL 62 46 70 64
VOLTAREN 59 38 73 58
LANTUS 59 24 73 116
POTASSIUM CHLORIDE 59 21 73 52
METOCLOPRAMIDE HCL 57 29 76 86
LEVEMIR FLEXPEN 56 21 77 172
NIASPAN 56 13 77 172
SINGULAIR 55 28 79 44
LANSOPRAZOLE 55 34 79 124
LISINOPRIL-HYDROCHLOROTHIAZIDE 54 40 81 67
OXYCODONE HCL-ACETAMINOPHEN 53 0 S2 82 177
HYDROCHLOROTHIAZIDE 52 20 83 22
RANITIDINE HCL 52 27 83 99
NITROSTAT 51 29 85 181
NOVOLOG MIX 70-30 50 13 86 187
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 24, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.